Trial Profile
BIOLUX RCT - Clinical Performance of the Pantera LUX Paclitaxel Releasing Balloon Versus the Drug Eluting Orsiro Hybrid Stent System in Patients With In-stent Restenosis - a Randomized Controlled Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Sep 2016
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Sirolimus
- Indications Coronary artery restenosis; Heart disorders
- Focus Therapeutic Use
- Acronyms BIOLUX-RCT
- Sponsors BIOTRONIK
- 23 Sep 2016 Status changed from active, no longer recruiting to completed.
- 23 Apr 2015 New trial record